Literature DB >> 23359579

Validation of rapid neurodevelopmental assessment for 2- to 5-year-old children in Bangladesh.

Naila Z Khan1, Humaira Muslima, Asma Begum Shilpi, Dilara Begum, Monowara Parveen, Nasima Akter, Shamim Ferdous, Kamrun Nahar, Helen McConachie, Gary L Darmstadt.   

Abstract

OBJECTIVE: Validate a tool to determine neurodevelopmental impairments (NDIs) in >2- to 5-year-old children in a country with limited child development expertise.
METHODS: Rapid Neurodevelopmental Assessment (RNDA) is a tool designed to detect functional status and NDIs across multiple neurodevelopmental domains. Validity was determined in 77 children enrolled by door-to-door sampling in Dhaka and who were administered the RNDA by 1 of 6 testers (4 developmental therapists, 2 special education teachers) and simultaneously administered a test of adaptive behavior (AB; Independent Behavior Assessment Scale) and intelligence quotient (IQ) tests (Bayley Scales of Infant Development II, Stanford Binet Intelligence Scale, Wechsler Preschool and Primary Scales of Intelligence) by psychologists.
RESULTS: Interrater reliability ranged from good to excellent. There were significant differences in AB in mean percentile scores on the Independent Behavior Assessment Scale for motor (P = .0001), socialization (P = .001), communication (P = .001), and full-scale (P = .001) scores in children with ≥1 NDI ("any NDI") versus no NDI. Significant differences in those with versus those without "any NDI" were found on IQ scores. Sensitivity and specificity for "significant difficulties" (defined as AB z-scores < -2 SDs and/or IQ <70) and "mild difficulties included" (AB z-scores < -1SD and/or IQ <85) were 90% and 60% and 80% and 76%, respectively.
CONCLUSIONS: The RNDA validity results are promising for use by child care professionals in field and clinical settings, but the tool needs further replication and refinement for assessment of specific impairments of vision, hearing, and seizures.

Entities:  

Mesh:

Year:  2013        PMID: 23359579     DOI: 10.1542/peds.2011-2421

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  Development of a 12 month screener based on items from the Bayley II Scales of Infant Development for use in Low Middle Income countries.

Authors:  Fred J Biasini; Desiree De Jong; Sarah Ryan; Vanessa Thorsten; Carla Bann; Roopa Bellad; Niranjana S Mahantshetti; Sangappa M Dhaded; Omrana Pasha; Elwyn Chomba; Shivaprasad S Goudar; Waldemar A Carlo; Elizabeth McClure
Journal:  Early Hum Dev       Date:  2015-03-02       Impact factor: 2.079

2.  Cultural adaptation of the Bayley Scales of Infant and Toddler Development, 3rd Edition for use in Kenyan children aged 18-36 months: A psychometric study.

Authors:  Megan S McHenry; Eren Oyungu; Ziyi Yang; Abbey C Hines; Ananda R Ombitsa; Rachel C Vreeman; Amina Abubakar; Patrick O Monahan
Journal:  Res Dev Disabil       Date:  2021-01-13

Review 3.  Child development assessment tools in low-income and middle-income countries: how can we use them more appropriately?

Authors:  Saraswathy Sabanathan; Bridget Wills; Melissa Gladstone
Journal:  Arch Dis Child       Date:  2015-03-30       Impact factor: 3.791

4.  Can Touch Screen Tablets be Used to Assess Cognitive and Motor Skills in Early Years Primary School Children? A Cross-Cultural Study.

Authors:  Nicola J Pitchford; Laura A Outhwaite
Journal:  Front Psychol       Date:  2016-10-25

5.  Detecting Developmental Delay and Autism Through Machine Learning Models Using Home Videos of Bangladeshi Children: Development and Validation Study.

Authors:  Qandeel Tariq; Scott Lanyon Fleming; Jessey Nicole Schwartz; Kaitlyn Dunlap; Conor Corbin; Peter Washington; Haik Kalantarian; Naila Z Khan; Gary L Darmstadt; Dennis Paul Wall
Journal:  J Med Internet Res       Date:  2019-04-24       Impact factor: 5.428

6.  Assessment of a neuro-developmental screening tool in children in Bhutan.

Authors:  Brian Wong; Sara Grundy; Lhab Tshering; Kinley Tshering; Farrah J Mateen
Journal:  Gates Open Res       Date:  2019-09-11

7.  Early detection of Australian Aboriginal and Torres Strait Islander infants at high risk of adverse neurodevelopmental outcomes at 12 months corrected age: LEAP-CP prospective cohort study protocol.

Authors:  Carly R Luke; Katherine Benfer; Leeann Mick-Ramsamy; Robert S Ware; Natasha Reid; Arend F Bos; Margot Bosanquet; Roslyn N Boyd
Journal:  BMJ Open       Date:  2022-01-07       Impact factor: 2.692

8.  Adaptation of the INTERGROWTH-21st neurodevelopment assessment (INTER-NDA) to the context of the English-speaking Caribbean.

Authors:  Randall Waechter; Roberta Evans; Sean Hanna; Toni Murray; Cassandra Mobley; Stephanie Holmes; Rashida Isaac; Rebeca Wolfe; Elbernezer Andrew; Barbara Landon; Michelle Fernandes
Journal:  BMC Pediatr       Date:  2022-01-04       Impact factor: 2.125

9.  Creation of the WHO Indicators of Infant and Young Child Development (IYCD): metadata synthesis across 10 countries.

Authors:  Melissa Gladstone; Magdalena Janus; Gillian A Lancaster; Gareth McCray; Patricia Kariger; Tarun Dua; Andrew Titman; Jaya Chandna; Dana McCoy; Amina Abubakar; Jena Derakhshani Hamadani; Günther Fink; Fahmida Tofail
Journal:  BMJ Glob Health       Date:  2018-10-15

10.  Quantifying long-term health and economic outcomes for survivors of group B Streptococcus invasive disease in infancy: protocol of a multi-country study in Argentina, India, Kenya, Mozambique and South Africa.

Authors:  Proma Paul; Simon R Procter; Mark Jit; Joy E Lawn; Ziyaad Dangor; Quique Bassat; Amina Abubakar; Sridhar Santhanam; Romina Libster; Bronner P Gonçalves; Shabir A Madhi; Azucena Bardají; Eva Mwangome; Adam Mabrouk; Hima B John; Clara Sánchez Yanotti; Jaya Chandna; Pamela Sithole; Humberto Mucasse; Patrick V Katana; Artemis Koukounari; Lois M Harden; Celine Aerts; Azra Ghoor; Shannon Leahy; Sibongile Mbatha; Sarah Lowick; Sanjay G Lala; Justina Bramugy; Charles Newton; A K M Tanvir Hossain; Qazi Sadeq-Ur Rahman; Philipp Lambach
Journal:  Gates Open Res       Date:  2021-07-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.